The next Ignition Sale is live on Bio! $GALE is an IP Token from @Cerebrum_DAO developing a novel treatment to fight brain inflammation using galectin-3 inhibition. Secure a GALE allocation on Bio:

Project Details: @NEURONGale Current treatments for Alzheimer's are ineffective and at best disease-slowing with side effects. Neuron Gale explores galectin-3 inhibition as a novel Alzheimer’s treatment to reduce plaques and neuroinflammation. Neuron Gale's team of neuroscientists will test a small molecule in an in vivo mouse model, aiming to open a new path in Central Nervous System drug discovery with far-reaching IP opportunities. ➤Market A disease-modifying galectin-3 inhibitor with compelling efficacy and safety profile could attain blockbuster drug status in a $1.44 trillion annual market, especially if positioned for early-stage or pre-symptomatic Alzheimer’s populations. ➤Team Neuron Gale is led by a team of neuroscientists and biotech entrepreneurs, including: • Dr. Maryna Polyakova: Neuroscientist leading the Neurotech Tree project at the Foresight Institute. • Dr. Peter Groenen: Biomarker & translational expert with 25 years of biopharma experience, having led numerous early research teams through late-stage R&D. • @Cerebrum_DAO: onchain research community backed by @BoostVC, advancing brain health research in various stages of drug screening & human trials.

Roadmap Neuron Gale will test a galectin-3 inhibitor in an Alzheimer’s mouse model. An orally available systemic galectin-3 inhibitor will be infused directly into the brain for a period of four weeks to test the research hypothesis.

Launch Details The GALE sale last 24 hours. To qualify for an allocation, pledge USDC and BioXP to the sale before it concludes Friday Nov 21 at 11am UTC. • Initial Raise: $50K • Starting FDV: $500K FDV • Total Potential Raise: $1.06M

@BahrainiCrypto @Cerebrum_DAO Issue was fixed

@fu_de54194 @Cerebrum_DAO Issue was fixed